drugset / Trial / NCT07308392
Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase II clinical trial evaluating the efficacy and safety of HRS-7249 and SHR-1918 in patients with severe hypertriglyceridemia at high risk of acute pancreatitis
Timeline
- Start
- 2026-02-25
- Primary completion
- 2027-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-7249 | Unknown | — | — |
| Subject | SHR-1918 | Monoclonal antibody | — | — |